CY1108640T1 - Χρηση αντισηπτικων δραστικων ουσιων σε ρμμα οστικα τσιμεντα - Google Patents

Χρηση αντισηπτικων δραστικων ουσιων σε ρμμα οστικα τσιμεντα

Info

Publication number
CY1108640T1
CY1108640T1 CY20081101438T CY081101438T CY1108640T1 CY 1108640 T1 CY1108640 T1 CY 1108640T1 CY 20081101438 T CY20081101438 T CY 20081101438T CY 081101438 T CY081101438 T CY 081101438T CY 1108640 T1 CY1108640 T1 CY 1108640T1
Authority
CY
Cyprus
Prior art keywords
active substances
bone cement
cements
raw bone
cement
Prior art date
Application number
CY20081101438T
Other languages
English (en)
Inventor
Frank Schilke
Berthold Nies
Hanns Pietsch
Original Assignee
Biomet Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomet Deutschland Gmbh filed Critical Biomet Deutschland Gmbh
Publication of CY1108640T1 publication Critical patent/CY1108640T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/206—Biguanides, e.g. chlorohexidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Αντικείμενο της εφεύρεσης είναι η χρήση της διγουανίδης πολυεξαμεθυλενίου σε ΡΜΜΑ οστικά τσιμέντα, τα οποία κατά προτίμηση δεν περιέχουν αντιβιοτικό, με μια συγκέντρωση δραστικής ουσίας επαρκή για την πρόληψη του μικροβιακού αποικισμού της επιφάνειας του τσιμέντου το πολύ 1% κατά βάρος σε σχέση με τη συνολική ποσότητα του τσιμέντου και τα οποία δεν επηρεάζουν σε διάρκεια τη διαδικασία επούλωσης του τραύματος.
CY20081101438T 2003-07-18 2008-12-10 Χρηση αντισηπτικων δραστικων ουσιων σε ρμμα οστικα τσιμεντα CY1108640T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10332680A DE10332680A1 (de) 2003-07-18 2003-07-18 Verwendung von antiseptischen Wirkstoffen in PMMA-Knochenzementen
EP04762421A EP1648531B1 (de) 2003-07-18 2004-07-16 Verwendung von antiseptischen wirkstoffen in pmma-knochenzementen

Publications (1)

Publication Number Publication Date
CY1108640T1 true CY1108640T1 (el) 2014-04-09

Family

ID=34071754

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101438T CY1108640T1 (el) 2003-07-18 2008-12-10 Χρηση αντισηπτικων δραστικων ουσιων σε ρμμα οστικα τσιμεντα

Country Status (15)

Country Link
US (1) US20060275339A1 (el)
EP (1) EP1648531B1 (el)
JP (1) JP2006528008A (el)
CN (1) CN1826146B (el)
AT (1) ATE409499T1 (el)
AU (1) AU2004259159B2 (el)
CA (1) CA2531488C (el)
CY (1) CY1108640T1 (el)
DE (2) DE10332680A1 (el)
DK (1) DK1648531T3 (el)
ES (1) ES2313046T3 (el)
PL (1) PL1648531T3 (el)
PT (1) PT1648531E (el)
SI (1) SI1648531T1 (el)
WO (1) WO2005009495A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4907643B2 (ja) * 2005-03-07 2012-04-04 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 医療用インプラント
DE102005048131A1 (de) * 2005-10-06 2007-04-12 Bayer Innovation Gmbh Antimikrobielle Kunststoffzusammensetzung mit niedriger Elutionsrate und langer Wirksamkeit
DE102008021473A1 (de) 2008-04-29 2009-11-12 Heraeus Kulzer Gmbh Mit Antiplaque-Wirkstoff(en) ausgestattete Dentalmaterialien
WO2009143236A1 (en) * 2008-05-20 2009-11-26 Albert Einstein Healthcare Network Compositions and methods for the treatment of skeletal metastatic lesions and fractures
DE102009004368A1 (de) * 2009-01-08 2010-07-15 Heraeus Kulzer Gmbh Dentalmaterialien enthaltend antimikrobielle Wirkstoffe zur Verhinderung von Plaque-Anlagerungen
DE102009035970A1 (de) * 2009-08-04 2011-02-17 Heraeus Kulzer Gmbh Antimikrobiell ausgestattete Dentalmaterialien, insbesondere zur Verhinderung von Plaqueanlagerungen
EP2384733B1 (de) * 2010-05-07 2016-07-27 Ivoclar Vivadent AG Antimikrobielle Dentalwerkstoffe
US8834772B2 (en) 2011-12-07 2014-09-16 Biomet Manufacturing, Llc Antimicrobial methacrylate cements
DE102012022419A1 (de) * 2012-11-16 2014-05-22 Heraeus Medical Gmbh Antiseptischer Polymethylmethacrylat-Knochenzement
DE102016212091A1 (de) 2016-07-04 2018-01-04 Heraeus Medical Gmbh Antiseptischer Polymethylmethacrylat-Knochenzement
CN114053477B (zh) * 2020-08-03 2023-06-06 首都医科大学附属北京朝阳医院 一种抗骨髓瘤纳米骨水泥及其制备方法与应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL200235A (el) * 1954-09-10
DE3513938A1 (de) * 1985-04-18 1986-10-23 Merck Patent Gmbh, 6100 Darmstadt Cytostatikahaltiges pharmakadepot
DE3542972A1 (de) * 1985-12-05 1987-06-11 Merck Patent Gmbh Pharmakadepot
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
EP0450117A1 (de) * 1990-04-02 1991-10-09 Infectless S.A. Ringerlösung und dessen Anwendung als bakterizid wirkendes lokales Wundbehandlungsmedikament
DE59406509D1 (de) * 1993-05-26 1998-08-27 Fresenius Ag Antiinfektivum
GB9322137D0 (en) * 1993-10-27 1993-12-15 Logical Water Limited A system and method for defining a process structure for performing a task
US6046143A (en) * 1994-08-22 2000-04-04 Becton Dickinson And Company Water soluble lubricant for medical devices
DE19641775A1 (de) * 1996-08-22 1998-02-26 Merck Patent Gmbh Verfahren zur Herstellung von wirkstoffhaltigen Knochenzementen
DE19718648A1 (de) * 1997-05-02 1998-11-05 Merck Patent Gmbh Verfahren und Vorrichtung zur Herstellung von steril verpacktem Knochenzement
US6245111B1 (en) * 1997-05-12 2001-06-12 Richard L. Shaffner Method and apparatus for fighting infection and maintaining joint spacing in a prosthesis implant area
US5980573A (en) * 1997-05-12 1999-11-09 Shaffner; Richard L. Method and apparatus for fighting infection and maintaining joint spacing in a prosthesis implant area
AUPO907697A0 (en) * 1997-09-09 1997-10-02 Day, Robert Edward Chemical supplementation of bone
US6020396A (en) * 1998-03-13 2000-02-01 The Penn State Research Foundation Bone cement compositions
EP0985413A1 (de) * 1998-08-06 2000-03-15 Jörg Michael Dr. Dr. Schierholz Medizinprodukte mit retardierter pharmakologischer Aktivität und Verfahren zu ihrer Herstellung
EP1161466A4 (en) * 1998-09-08 2002-04-10 Microban Products ANTIMICROBIAL ACRYLIC MATERIAL
WO2000016712A2 (en) * 1998-09-24 2000-03-30 Advantage Dental Products, Inc. Calcified tissue facing preparation containing an antimicrobial agent
DE19938704C1 (de) * 1999-08-14 2001-10-31 Ivoclar Vivadent Ag Verfahren zur Herstellung von Reaktionssystemen zur Implantation in den menschlichen und tierischen Körper als Knochenersatz, die u.a. Calcium und Phosphor enthalten
MXPA03001406A (es) * 2000-08-15 2004-05-04 Surmodics Inc Matriz de incorporacion de medicamento.
ES2192141B1 (es) * 2002-02-08 2005-02-16 Consejo Sup. Investig. Cientificas Formulaciones acrilicas de curado en frio con activadores derivados de diaminodifenilcarbinol de baja toxicidad.

Also Published As

Publication number Publication date
PL1648531T3 (pl) 2009-03-31
DE10332680A1 (de) 2005-02-17
US20060275339A1 (en) 2006-12-07
SI1648531T1 (sl) 2009-02-28
CA2531488C (en) 2010-09-28
WO2005009495A1 (de) 2005-02-03
CA2531488A1 (en) 2005-02-03
AU2004259159A1 (en) 2005-02-03
EP1648531A1 (de) 2006-04-26
DE502004008161D1 (de) 2008-11-13
DK1648531T3 (da) 2009-01-12
PT1648531E (pt) 2008-12-05
CN1826146A (zh) 2006-08-30
ES2313046T3 (es) 2009-03-01
AU2004259159B2 (en) 2008-11-20
ATE409499T1 (de) 2008-10-15
CN1826146B (zh) 2010-12-01
EP1648531B1 (de) 2008-10-01
JP2006528008A (ja) 2006-12-14

Similar Documents

Publication Publication Date Title
CY1108640T1 (el) Χρηση αντισηπτικων δραστικων ουσιων σε ρμμα οστικα τσιμεντα
DE60228749D1 (de) Cephalosporin verbindungen enthaltende zusammensetzungen und deren verwendung zur behandlung von bakteriellen infektionen bei hunden und katzen
DK1440148T3 (da) Keratinocytter anvendelige som biologisk aktive substanser i behandling af sår
GB0325565D0 (en) Improvements in or relating to organic compositions
DE602004028359D1 (de) Reinigung von biologisch produziertem 1,3-propandiol
SE0102315D0 (sv) Compounds
TNSN08070A1 (en) Benzoquinazoline derivatives and their use in treating bone disorders
DE602004030810D1 (de) Implantate mit befestigten silylierten therapeutischen mitteln
DOP2002000447A (es) 1-alquil o 1-cicloalquiltriazolo [4,3-a] quinazolin-5 onas como inhibidores de fosfodiesterasas
CY1106958T1 (el) Ν-αλκυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακα
DE50308301D1 (de) Anlage zur Herstellung von Zementklinker
TW200630367A (en) Substituted adenines and the uses thereof
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
MA28613B1 (fr) Macrocycles d'amide antibacteriens
CO5690590A2 (es) Uso de tigeciclina sola o en combinacion con rifampicina para tratar la osteomielitis y/o la artritis septica
UY28542A1 (es) Amidas macrocíclicas antibacterianas
CL2007001910A1 (es) Compuestos derivados de penem; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
ATE325079T1 (de) Mikrobiologische zusammensetzung
SE0102858D0 (sv) N-type calcium channel antagonists for the treatment of pain
MX2007014297A (es) Derivados de purina y su uso para el tratamiento de enfermedades autoinmunes.
CL2008002223A1 (es) Compuestos derivados de 9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a 2'-o-sustituida; proceso de preparación; compuesto intermediario; composición farmacéutica; y su uso en el tratamiento y/o profilaxis de la malaria.
BRPI0409586A (pt) ácidos hidroxámicos úteis no tratamento de distúrbios hiperproliferativos
ATE442122T1 (de) Dentalmaterial mit bakteriostatischen und/oder bakteriziden substanzen
BR0210958A (pt) Heterociclos de benzonitrogênio substituìdos
FI6007U1 (fi) Biologisen jätteen käsittelylaitteisto